Jamia Millia Islamia university’s biotechnology department has been rated one of the top 10 public institutes of India in a nationwide survey, a university official said Monday.
Jamia Millia Islamia university’s biotechnology department has been rated one of the top 10 public institutes of India in a nationwide survey, a university official said Monday.
Tamir Biotechnology, Inc.(formerly Alfacell Corporation) announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) confirmed that testing of three of our company’s compounds showed in vitro results rarely seen before by the U.S. government for yellow fever.
Dubai, Aug 10th, 2010 (WAM) — The first educational institution in the region that offers biotechnology degrees opened in Dubai under the name of Biotechnology University College (BUC). The college has started to receive applications for registration and to introduce its programs in the biotechnology major that has become very significant in these days.
SOUTH EASTON, Mass. — Pressure BioSciences, Inc. today announced that two leading biotechnology publications with worldwide readership and importance have highlighted the Company’s powerful and enabling pressure cycling technology platform in their just released August issues.
A review commissioned by the Biotechnology and Biological Sciences Research Council (BBSRC) shows that the Biotechnology Young Entrepreneurs Scheme (YES) – now in its 15th year gives early career researchers the edge in entrepreneurial skills and future career prospects. The Biotechnology Young Entrepreneurs Scheme (YES) is an annual business plan competition designed to raise awareness of …
MELBOURNE, AUSTRALIA–(Marketwire – August 3, 2010) – Prana Biotechnology ( NASDAQ : PRAN ) ( ASX : PBT ) today announced that Professor Rudolph Tanzi, Professor of Neurology at Harvard Medical School, co-founding scientist of Prana Biotechnology, and current member of Prana’s R&D Board, was quoted in the July 29 th , 2010 article in New Scientist titled, “Alzheimer’s Unlocked: New Keys to a …
TAMPA, Fla.—-Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim’s automated system for Deviation and Corrective and Preventive Action management using its on-demand software as a service platform.
Background:
Simultaneous saccharification and co-fermentation (SSCF) has been recognized as a feasible option for ethanol production from xylose-rich lignocellulosic materials. To reach high ethanol concentration in the broth, a high content of water-insoluble solids (WIS) is needed, which creates mixing problems and, furthermore, may decrease xylose uptake. Feeding of substrate has already been proven to give a higher xylose conversion than a batch SSCF. In the current work, enzyme feeding, in addition to substrate feeding, was investigated as a means of enabling a higher WIS content with a high xylose conversion in SSCF of a xylose-rich material. A recombinant xylose-fermenting strain of Saccharomyces cerevisiae (TMB3400) was used for this purpose in fed-batch SSCF experiments of steam-pretreated wheat straw.
Results:
By using both enzyme and substrate feeding, the xylose conversion in SSCF could be increased from 40% to 50% in comparison to substrate feeding only. In addition, by this design of the feeding strategy, it was possible to process a WIS content corresponding to 11% in SSCF and obtain an ethanol yield on fermentable sugars of 0.35 g g-1.
Conclusion:
A combination of enzyme and substrate feeding was shown to enhance xylose uptake by yeast and increase overall ethanol yield in SSCF. This is conceptually important for the design of novel SSCF processes aiming at high-ethanol titers. Substrate feeding prevents viscosity from becoming too high and thereby allows a higher total amount of WIS to be added in the process. The enzyme feeding, furthermore, enables keeping the glucose concentration low, which kinetically favors xylose uptake and results in a higher xylose conversion.
WORCESTER, Mass. — Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has created a scientific advisory board in an effort to further its drug development programs, specifically in the areas of oncology and metabolic diseases.
Two area technical colleges will partner this fall to provide students with state-of-the-art training in biotechnology.
DALLAS — MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. . The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
BALTIMORE, July 28 /PRNewswire-FirstCall/ — Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010. Full details of the Company’s financial results will be available in the Company …
After a steady upward move at the open, biotechnology stocks are seeing notable strength in late morning trading on Monday. The NYSE Arca Biotechnology Index is up by 2.3 percent and set a one-month intraday high earlier in the session.
Biotechnology company Genzyme Corp is weighing an informal takeover approach from France’s Sanofi-Aventis but is not looking to sell the company, a source familiar with the situation said on Monday.
Beike Biotechnology Co. Ltd. , one of the world’s leading biotechnology companies focusing on adult stem cell therapies, opened Romania’s first rehabilitation center to use traditional Chinese-style rehabilitation techniques in Campina today.
1. Switzerland’s Cytos Biotechnology and Singapore ’s Agency for Science, Technology and Research (A*STAR) jointly announced today their first collaboration on a virus-like particle (VLP) vaccine.
( Agency for Science, Technology and Research (A*STAR), Singapore ) Switzerland’s Cytos Biotechnology and Singapore’s Agency for Science, Technology and Research jointly announced today their first collaboration on a virus-like particle (VLP) vaccine. This partnership, which involves academic and clinical partners across Singapore, aims at research, development and commercialization of a VLP …
Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first “composition of matter” patent to be issued relating to one of their development products.
DUBLIN—-Research and Markets has announced the addition of the “Biotechnology Sector” report to their offering.
July 12, 2010. In the coming decades, James Canton, a world-renowned futurist, foresees that biotechnology, ICT, nanotechnology, and neurotechnology will be the areas of radical innovation and source of a huge chunk of the global wealth in the next five, ten, and twenty years. Among these top trends that will…
The University of Texas Health Science Center at Houston (UTHealth) announced that its Biotechnology Commercialization Center (BCC) has leased more than three-quarters of its available space to eight Texas-based startups in less than a year. The center’s focus is to assist biotech entrepreneurs and small companies with the translation of discoveries into innovative health solutions.
WORCESTER, Mass. — Generex Biotechnology Corporation today announced its participation in the Gateway to China Business Round Table Conference held in Orlando, Florida June 28 & 29.
Mobile phone recycling is a fast increasing notion that is taking the world by storm, and a way of earning yourself some additional money. Even so, people across the world are still very much unacquainted towards the potential behind this new cash earning arrangement.
Should you or any person you know have any old mobile phones lying around their abode then now is the best time to see how much they could be worth by using a mobile phone recycling comparison website like SellMyMobile.com, and the course of action couldn’t be any simpler. When you come to sell your mobile, you can calculate all the UK’s leading mobile phone recycle companies to give you the utmost price possible on your broken, unused or even new mobile phone, saving you time and cash from having to actually visit each web site and take note of the prices.
The course of action to selling your phones for money is clear-cut and will literally only take you a matter of minutes to finalize. To sell mobile handsets simply search for your phone, look out for the best price label and send it in using information that will be emailed across to you. It doesn’t cost you a penny and you will obtain the money for it within the post within several working days. Help declutter your house, get yourself some extra money, and help the environment by recycling your mobile phones with SellMyMobile.com.
SOMERSET, N.J. — Tamir Biotechnology, Inc. today announced that it has selected Pharmatech Oncology, Inc. as the Clinical Research Organization to run its upcoming Phase II trial of RANPIRNASE (ONCONASE) in combination with platinum doublet chemotherapy for patients with advanced or metastatic non-squamous, non-small cell lung cancer .